Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long-Term Disease Control: An Observational Study-Reference-Cited by-同舟云学术

Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long-Term Disease Control: An Observational Study

Published:2018-03-07 Issue:4 Volume:70 Page:582-591
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Ruiz-Arruza Ioana¹,Lozano Jesús²,Cabezas-Rodriguez Ivan³,Medina Jose-Alejandro⁴,Ugarte Amaia¹,Erdozain José-Gabriel¹,Ruiz-Irastorza Guillermo¹

Affiliation:

1. Biocruces Health Research Institute; Hospital Universitario Cruces; University of The Basque Country; Bizkaia The Basque Country Spain

2. Biocruces Health Research Institute; Hospital Universitario Cruces; University of The Basque Country, Bizkaia, The Basque Country; and Hospital Universitario J. M. Morales Meseguer; Murcia Spain

3. Biocruces Health Research Institute; Hospital Universitario Cruces; University of The Basque Country, Bizkaia, The Basque Country; and Hospital Universitario Central de Asturias; Oviedo Asturias Spain

4. Biocruces Health Research Institute; Hospital Universitario Cruces; University of The Basque Country, Bizkaia, The Basque Country; and Complejo Hospitalario Universitario Nuestra Sra. de Candelaria; S/C de Tenerife Spain

Funder

Fundacion Jesus Gangoiti Barrera

Publisher

Wiley

Subject

Rheumatology

Reference54 articles.

1. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients;Cervera;Medicine (Baltimore),2003

2. Mortality in systemic lupus erythematosus;Bernatsky;Arthritis Rheum,2006

3. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus;Urowitz;J Rheumatol,2008

4. Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years;Chambers;Rheumatology (Oxford),2009

5. Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis;Lee;Lupus,2016

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cumulative pulse methylprednisolone and its relation to disease activity, damage and mortality in systemic lupus erythematosus patients: A post hoc analysis of COMOSLE-EGYPT study;Clinical Rheumatology;2024-01-10

2. KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS;Kidney International;2024-01

3. Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus;Expert Review of Clinical Immunology;2023-12-19

4. Successful glucocorticoid withdrawal in Chinese lupus nephritis patients: A single centre experience;International Immunopharmacology;2023-12

5. Systemic lupus erythematosus and glucocorticoids: A never-ending story?;Best Practice & Research Clinical Rheumatology;2023-11